Summary
Pursuant to the National Drugs Strategy, task 2.7 “Research and monitoring”, the National Bureau conducted a mid-term evaluation of the National Drugs Strategy (KPPN). The aim of the evaluation was to list activities that have not been completed and identify challenges in implementing action in the three main areas of the KBPN: prevention, treatment and supply reduction.
Download as PDF
PDF files are made available as a convenience. In cases where the EMCDDA is not the originator of the document, please be aware that any PDFs available on this page may not be authoratative or there may be more recent versions available. While we make every effort to ensure that these files are definitive, before using or citing them, we recommend that you consult the publisher's website or contact the author(s) to check for more recent versions.